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Kalman B, Li S, Chatterjee D, O’Connor J, Voehl MR, Brown MD, Alder H. Large scale 
screening of the mitochondrial DNA reveals no pathogenic mutations but a haplotype 
associated with multiple sclerosis in Caucasians. Acta Neurol Scand. 1999;99:16-25. 
 
Nash DB. Disease management programs: where do we go from here? Drug Benefit 
Trends. 1999;11(5):68-71. 
 
Risk Contracting and Capitation Management: A Colloquy. Dove HG, Calabrese D, 
Gosfield AG, Miele MS, Nash DB, Thygeson NM (eds). Totowa, NJ: Emron, Inc., June 
1999. 
 
Rosenthal G. Making the case for quality: an interview with David Nash. The Joint 
Commission Journal on Quality Improvement. 1999;25(5):259-264. 
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COMING SOON 
 
Connecting with the New Healthcare Consumer: Defining Your Strategy. 
Nash DB, Manfredi MP, Howell SL, Bozarth BL (eds). Burr Ridge, IL: McGraw-Hill 
Healthcare Education Group. Publication: October 1999. 
 
...A multiauthored book on the new “consumerism” in healthcare, designed for 
healthcare providers and professionals across the spectrum who want to gain a 
better understanding of the impact of this unprecedented revolution on the 
healthcare industry; and of their consumer markets, toward optimizing strategies 
that bind consumers and those who serve them more closely together. 
